Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Deep Sea Water (DSW) is a naturally sourced mineral water obtained from ocean depths typically exceeding 200 meters, where the water is characterized by high purity, low temperature, and a distinct mineral profile including magnesium, calcium, and potassium. National Taiwan University Hospital has conducted clinical research, including Phase 3 trials, to evaluate the antibacterial efficacy of DSW against *Helicobacter pylori* infection. The intervention involves the oral consumption of DSW, with the hypothesis that its unique mineral composition can inhibit the growth and colonization of *H. pylori* in the stomach. This approach is being explored as a potential non-pharmacological or complementary therapy to reduce the risk of *H. pylori*-associated conditions such as gastritis, peptic ulcers, and gastric cancer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Deep Sea Water.